Target intelligence / Profile preview

Leucine rich repeat containing 34 pseudogene 1 (LRRC34P1)

Target
LRRC34P1
Molecular classification
Other (Pseudogene)
01

Overview

Leucine rich repeat containing 34 pseudogene 1 (LRRC34P1) is classified as a *pseudogene*, meaning it is a genomic locus that resembles a protein-coding gene (in this case, related to the LRRC34 gene) but is generally considered non-functional at the protein level[1][6]. Pseudogenes are sometimes transcribed into RNA, and some have demonstrated regulatory roles such as acting as competing endogenous RNAs (ceRNAs) or generating noncoding RNAs that affect expression of protein-coding genes[2][5][6]. However, there is **no evidence that LRRC34P1 has a defined biological function, participates in disease, serves as a drug target, or acts as a biomarker** in any clinical or research setting to date[1]. It inherits its name from sequence similarity to the protein-coding gene LRRC34, which is involved in stem cell regulation and differentiation[3], but LRRC34P1 itself is noncoding. No data support its classification as a **therapeutic target** or suggest clinical relevance for diagnostics, safety, or drug development[1]. The pseudogene does not encode a functional protein nor does it have catalogued regulatory or disease-associated roles. **Note:** - The entry is correct (the gene exists as a NCBI and HGNC entry as a pseudogene) but is **not a valid drug target** or receptor per canonical definitions[1][6]. - No meaningful aliases or alternative names are reported beyond its standard nomenclature and database identifiers[1].

02

Mechanism of action

None

03

Biological functions

Possibly noncoding RNA regulation (general for pseudogenes)
04

Disease associations

None established for LRRC34P1; no known direct involvement in disease (General: Some pseudogenes have roles in cancer and other diseases, but no evidence for LRRC34P1 specifically.)

Beyond the preview

Go deeper on Leucine rich repeat containing 34 pseudogene 1 (LRRC34P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine rich repeat containing 34 pseudogene 1 (LRRC34P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call